Improving Health Literacy in African-American Prostate Cancer Patients
Launched by EMORY UNIVERSITY · Oct 23, 2017
Trial Information
Current as of September 24, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how African-American men with early-stage prostate cancer understand conversations about their treatment options. The researchers want to see if giving patients an easy-to-understand educational guide after their visit with the urologist (a doctor who specializes in urinary and prostate health) can help improve their knowledge about treatments and possible side effects. The goal is to help patients feel more informed and confident when making decisions about their care.
Men who have recently been diagnosed with early-stage prostate cancer through a biopsy reviewed at certain hospitals in Atlanta may be able to join. To participate, they should not have certain medical or cognitive conditions that affect understanding, and they must be able to communicate in English. During the study, participants will have interviews to share their experiences and receive the educational guide after their doctor visit. This study is currently looking for volunteers who meet these criteria.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who have undergone pathology review of their prostate biopsy at Emory University, Grady Memorial Hospital, Saint Joseph's Hospital, and Atlanta VA Medical Center with AJCC clinical stage T1-T2 prostate cancer by physical exam
- Exclusion Criteria:
- • RN or MD degree
- • History of head injury or dementia
- • History of cognitive impairment
- • Unable to undergo the informed consent process and the study interview in English per the judgment of the primary urologist or urological provider
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Patients applied
Trial Officials
Kerry Kilbridge, MD
Principal Investigator
Dana-Farber Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials